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INTRODUCTION:  Core  needle  biopsy  has  become  the preferred  method  of  diagnosing  breast  carcinomas
prior  to deﬁnitive  surgery.  The  possibility  of displacing  tumor  cells  into  the  needle  track  is a concern.
PRESENTATION  OF  CASE:  A 38 year  old  woman  was diagnosed  with right  breast  ductal  carcinoma  in situ
(DCIS)  with  microinvasion  by core needle  biopsy.  Bilateral  skin  sparing  mastectomies  with  immediate
autologous  reconstruction  were  performed.  One  and  a half  years  later  the  patient  noted  erythema  and  a
scaling  crust  on  the  skin  of  the  right  breast  that  progressed  over  several  months.  Punch  biopsy  revealed
Paget  disease  restricted  to  the  epidermis.  Subsequent  comparison  to initial  clinical  photographs  con-
ﬁrmed  the  cancer  was associated  with  the  skin  puncture  site  of the  needle  biopsy.  The  patient  underwent
complete  excision  with  skin  grafting  and  remains  free  of  disease  three  years  later.
DISCUSSION: Only  13 cases  of  needle  track  recurrences  have  been  reported.  The  majority  presented  as
invasive  carcinoma  forming  a subcutaneous  mass.  In the current  case,  detection  was  delayed  due  to  not
initially  noting  that  a skin  lesion  was  at the puncture  site  of the  original  needle  biopsy.  This  is  the  only
case  of recurrence  as  tumor  limited  to the  epidermis.
CONCLUSION:  Although  recurrence  in  a needle  track  occurs  very  infrequently,  clinicians  should  be  aware
of  this  phenomenon  and  investigate  any  changes,  particularly  when  occurring  at a needle  biopsy  site.
Recording  the skin  puncture  site  can  aid in  early  detection  of  recurrences.  Recognition  of a  recurrence  is
important  for prompt  treatment  and  optimal  prognosis.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Needle biopsies have become the preferred method for the ini-
ial evaluation of breast lesions. Patients with benign ﬁndings are
pared surgical excision and patients with malignant ﬁndings can
ave deﬁnitive surgery planned. There has been a long-standing
oncern about the possibility of needle track seeding leading to
ocal breast cancer recurrence [1]. Fortunately, recurrences in
he needle track are exceedingly rare. We  report the case of a
oman treated for ductal carcinoma in situ DCIS and one focus
f microinvasion with mastectomy and autologous reconstruction,
ho recurred with DCIS involving the epidermis (Paget disease of
he skin) at the skin puncture site of the original core needle biopsy.
∗ Corresponding author at: Department of Pathology, Brigham and Women’s Hos-
ital, 75 Francis Street, Boston, MA  02115, United States. Fax: +1 617 264 5118.
E-mail address: slester@partners.org (S.C. Lester).
ttp://dx.doi.org/10.1016/j.ijscr.2015.08.041
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Assoc
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case report
A 38 year old woman  at high risk of breast cancer due to prior
radiation for Hodgkin disease was  discovered to have an area of
calciﬁcations in the lower inner quadrant of the right breast on
her ﬁrst screening mammogram. No skin lesions were present and
the nipple was  normal in appearance. A 10 gauge vacuum-assisted
core needle biopsy successfully sampled the calciﬁcations and a
marking clip was  placed. The needle entered the breast at approx-
imately 5:00 (Fig. 1). The biopsy revealed high grade DCIS with
comedo necrosis and calciﬁcations. A single focus was suspicious
for microinvasion. The DCIS was negative for estrogen receptor
(ER), showed 1–4% positivity for progesterone receptor (PR), and
was positive for HER2 (3+). Breast MRI  showed a corresponding
2.5 × 1.0 cm area of enhancement in the area of the DCIS, located
5.3 cm away from the nipple.
The patient opted to undergo bilateral skin sparing mastec-
tomies with immediate reconstruction using pedicled transverse
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. This photograph was taken by the plastic surgeon as part of routine pre-
surgical planning for breast reconstruction. The diagnostic core needle biopsy skin
entrance site is visible in the lower inner quadrant of the right breast (arrow). The
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Fig. 3. Three years after mastectomy, the lesion had increased to a size of 2 cm and
now appeared eroded (arrow). It was noted at this time that the lesion was  presentite  is located away from the patient’s nipple, which is normal in appearance, and
o  other skin lesions are present. It was fortuitous that the photograph was taken
hortly after the core needle biopsy before the skin puncture site had healed.
ectus abdominus myocutaneous (TRAM) ﬂaps. The nipple and are-
lar complexes were removed, but the skin in the area of the prior
eedle biopsy site was preserved. The right mastectomy revealed
CIS with 2 foci of microinvasion over 3–4 cm.  The skin, nipple,
uperﬁcial skin ﬂap margin, and deep margin were free of carci-
oma, as were 3 sentinel nodes.
One and a half years after the mastectomy, the patient noted an
rea of skin change in the lower inner aspect of the right recon-
tructed breast (Fig. 2). This area was not close to the mastectomy
car or the reconstructed nipple. The lesion measured 1.2 cm but
radually increased in size and was treated by her primary care
hysician with topical antifungal medication. The skin lesion con-
inued to enlarge and was brought to the attention of her breast
urgical oncologist three years after her mastectomy. The erythe-
atous lesion now measured 2.5 × 2.0 cm and appeared eroded
Fig. 3). Photographs taken by her plastic surgeon prior to her
ig. 2. One and a half years after mastectomy, the patient developed an erythema-
ous skin lesion. Over the next several months, this lesion continued to increase in
ize (arrow). The nipple has been reconstructed.at  the site of the prior core needle biopsy based on the clinical photograph in Fig. 1.
A  skin punch biopsy was performed.
mastectomy and reconstruction fortuitously showed the skin punc-
ture site of the original core needle biopsy (Fig. 1). It was apparent
that the skin lesion was  at this same site. A skin punch biopsy was
performed and revealed tumor cells restricted to the epidermis
(Paget disease).
The entire area of involved skin was  excised to negative mar-
gins. Because of the size and location of the lesion, full thickness
skin grafting was necessary for cosmetic closure. The carcinoma
was restricted to the epidermis over a 1.7 cm area (Fig. 4). The
carcinoma was negative for ER, showed low levels of PR, and was
strongly positive for HER2. No invasion was present. No evidence
of an ectopic nipple, Toker cells, residual breast tissue, or apocrine
glands was seen. Therefore the most likely source of the tumor cells
was iatrogenic displacement of tumor cells from the breast into the
epidermis from the prior core needle biopsy. The patient is without
Fig. 4. The skin punch biopsy and subsequent complete skin excision revealed
tumor cells involving the epidermis. No invasion of the dermis was  seen. There was
no  evidence of an ectopic nipple, apocrine glands, or eccrine gland involvement.
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Table 1
Cases of recurrent cancer in the needle track after deﬁnitive surgical treatment.
Study Biopsy type Primary
carcinoma
ER HER2 Surgery XRT Systemic
treatment
Time to
recurrence
Recurrent
carcinoma
Location of
recurrence
Thurfjell et al. [7] FNA Adenoid cystic Unknown Unknown BCT No Unknown 4.1 years Adenoid cystic Breast
FNA  Invasive
mucinous
Unknown Unknown BCT No Unknown 2.5 years Invasive
mucinous
Breast
FNA  Invasive
tubuloductal
Unknown Unknown BCT No Unknown 2.1 years Invasive
tubuloductal
Breast
Chao  et al. [8] 14G stereo CNB Invasive ductal − Unknown M No Unknown 1.4 years Invasive ductal Subcutaneous
14G  CNB Invasive ductal + Unknown M No AC, tam 1 year Invasive ductal Unknown
Intra  et al. [9] FNA
CNB
DCIS + + M No No 2 years Invasive ductal Muscle
Uriburu  et al. [10] 14G stereo CNB Invasive
mucinous
+ Unknown M SS No CMF  1.9 years Invasive with
mucin
Dermis and
subcutaneous
14G  stereo CNB Invasive ductal + − M SS No Unknown 1.8 years Invasive ductal Dermis and
subcutaneous
14G  stereo CNB Invasive ductal + + M SS No Unknown 1.3 years Invasive ductal Subcutaneous
Kwo  and
Grotting [11]
CNB Not speciﬁed Unknown Unknown M SS No No 6 years Not speciﬁed Skin
Brouwer  et al. [12] 14G CNB Invasive ductal + + M SS No No 1.1 years Invasive ductal Skin and
dermis
Invasive
ductal/lobular
+  − M SS No No 1.2 years Invasive Skin and
dermis
Kawasaki  et al.
[13]
16G CNB Well
differentiated
neuroen-
docrine
tumor
+ − BCT No Aromatase
inhibitor
3.9 years Well
differentiated
neuroen-
docrine
tumor
Skin and
subcutaneous
tissue
Current  study 10G stereo CNB DCIS with
microinvasion
− + M SS No No 1.5 years Paget disease
(DCIS)
Epidermis
FNA, ﬁne needle aspiration; stereo CNB, stereotactic core needle biopsy; DCIS, ductal carcinoma in situ; ER, estrogen receptor; BCT, breast conserving therapy; M,  mastectomy; SS, skin sparing; XRT, radiation therapy; CMF,
cyclophosphamide, methotrexate, and 5-ﬂuorocuracil; AC, adriamycin, cytoxan; tam, tamoxifen.
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vidence of carcinoma, 3 years after the skin excision and 6 years
fter mastectomy.
. Discussion
Adenocarcinoma between an intact basement membrane and
n overlying normal epithelium is classiﬁed as Paget disease. The
ost common cause in the breast is DCIS extending from breast
ucts into the epidermis of the nipple areolar complex. In the cur-
ent case, the Paget disease was located away from the nipple and
ther etiologies had to be considered. Paget disease can arise from
n ectopic nipple [2,3]. However, the location was  far from the
ormal milk line along which ectopic nipples usually occur and a
reviously existing nipple was not observed. Extramammary Paget
isease is thought to arise from apocrine glands, as it occurs in
he genital, perianal, and axillary areas [4,5]. However, the recur-
ence was far from the axilla and no apocrine glands were present.
ery rare cases of “ectopic” extramammary Paget disease occur in
kin without apocrine glands and may  arise from eccrine glands
6]. This disease most commonly involves the trunk of elderly
ales. No involvement of eccrine glands was seen in the current
ase.
The only likely remaining mechanism for this case of Paget dis-
ase is displacement of tumor cells from the original DCIS to the
pidermis from tumor seeding the needle track. This possibility is
upported by the identical histologic appearance and tumor marker
xpression of the original and recurrent carcinomas and the loca-
ion at the core needle biopsy site.
Carcinoma recurring in a needle track as Paget disease of the
kin has not been reported previously. There are only 13 other
ases of breast cancer recurrence in a needle track after deﬁni-
ive surgery and a disease- free interval (Table 1) [7–13]. Eleven
f the cases were invasive cancers, one was DCIS, and one was  not
peciﬁed. The time to recurrence ranged from 1 to 6 years (aver-
ge 2.5 years). Three patients who underwent breast conservation
ecurred as invasive carcinoma in the breast and 1 recurred in the
kin. Seven of 9 patients who underwent mastectomy recurred as
nvasive carcinomas involving the skin and subcutaneous tissue.
ne patient recurred as invasive carcinoma in skeletal muscle. The
ite of recurrence was not speciﬁed for 1 patient. All but 1 patient
ad carcinoma limited to the core needle site. This patient had mul-
iple foci of carcinoma in the dermis in the same quadrant [10]. She
ad presented with 3 invasive carcinomas and had undergone 3
ore needle biopsies.
Epithelial displacement into needle tracks immediately after the
rocedure has been shown to be quite common [1,14]. How then,
oes one explain the scarcity of clinically evident recurrences? The
ikelihood of ﬁnding cells in the needle track diminishes over time,
upporting that, in many cases, these cells do not persist, perhaps
ue to lack of a developed blood supply [15]. It is also possible that
adiation therapy plays a role, as none of the patients with needle
rack recurrences received this therapy. The possible role of sys-
emic therapy is less clear. Two patients received chemotherapy, 6
id not, and this information is not provided for the other 5 patients
Table 1). Finally, removal of the needle track as part of the intended
urgical resection or as a separate excision will eliminate any resid-
al cells, though the utility of such a minor risk-reducing maneuver
t the expense of likely cosmetic compromise may  be debatable.
There are no deﬁnite risk factors for needle track recurrences.
eedle track seeding has not been clearly associated with the type
nd size of needles, the number of needle passes, or the duration of
he procedure [1]. Recurrences have been associated with both ﬁne
eedle aspirations and core needle biopsies (Table 1). Although 5 of
he cancers were of special histologic types, this association may  be
elated to the decision not to radiate rather than the type of cancer.PEN  ACCESS
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The rarity of clinically diagnosed needle track recurrences sup-
ports that routine excision of the skin and needle track is not
required, especially for women  undergoing radiation therapy. It
has been suggested that it would be helpful to document the site
of the biopsy with a diagram or photograph in the patient’s medi-
cal record [12]. The location of the skin puncture site for a needle
biopsy depends on the location of the lesion, the imaging modality
used, and the size of the breast and cannot be determined with cer-
tainty unless recorded before the site heals. The need to document
biopsy sites may  be questioned due to the low number of reported
recurrences. However, in the absence of knowing the location of
the skin puncture, recurrences may  be underreported. Documen-
tation can also aid in early detection of recurrences. In the reported
case, diagnosis was delayed for over a year as the skin lesion was
mistaken for an infection. Fortunately, the carcinoma was  detected
while still in situ. Invasion can occur from Paget disease and the
delay in diagnosis could have resulted in development of invasive
carcinoma and a poorer prognosis [16,17].
The reported recurrences have been successfully treated with
local excision and adjuvant treatment. Although follow-up is short,
no cases have been reported with distant metastasis. It is impor-
tant to recognize a skin recurrence as an isolated needle track
recurrence, as this type of recurrence may  not have the same dire
prognosis for recurrent invasive carcinoma elsewhere in the chest
wall [18,19].
4. Conclusions
Needle track recurrences after diagnosis and treatment of car-
cinoma are rare and have not been reported in patients receiving
radiation therapy. For patients not receiving radiation, and whose
needle track will not be removed by the planned surgery, documen-
tation of the location of the skin puncture site in the patient’s chart
may  be of value. This can aid in the early detection of a recurrence
as a subcutaneous mass or as changes in the skin. Early detection,
especially for recurrences as DCIS as in the described case, can avoid
possible poor clinical outcomes.
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